Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease
Clinical trial NCT06114329 · UNKNOWN
Trial details
- NCT number
- NCT06114329
- Sponsor
- AceLink Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2024-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.